Psychiatry Flashcards
What is Alzheimer’s disease
A neurodegnerative syndrome with progressive decline in several cognitive domains
Atrophy of the cerebral cortex and formation of amyloid plaques and neurofibrillary tangles and acetylcholone production in affected neurones is reduced
What is the epidemilogy of Alzheimer’s disease
50-75% of dementia cases
800,000 people in the UK have dementia
Prevalence of dementia increases with age with 20% of people over 80 known, although ~half of likely cases have actually been diagnosed
Similar prevalence in men and women
What is the aetiology of Alzheimer’s disease
Formation of beta amyloid plaques and neurofibrillary tangles
Neuronal loss is selective - the hippocampus, amygdala, temporal neocortec and subcortical nuclei
Cerebral atrophy (medial temporal lobe), senile plaques, amylpid deposition, neuro-fibrillary tangles, acetyle choline levels reduced
95% of AD pts show evidenc of VD too
How does Alzheimer’s disease present
5 A’s of Alzheimers:
Amnesia - memory loss (short term goes first)
Aphasia - inability to speak, write or understand language both written and verbal
Agnosia - inability to recognise sensory stimuli
Apraxia - inabiltiy to perform learned movements on command
Associated behaviours - disorientation, misplacing items, decline in activities of daily living, personality changes
Mood changes - depressed, apathetic, irritable
Poor abstract thinking - complex tasks requiring organisation and planning become difficult
Construction dyspraxia - parietal lobe deficits may lead to difficulties completing clock-drawing test
How is potential Alzheimer’s disese assessed
Use neuropsychological testing (mini-mental state exam, Montreal cognitive assessment) in those with memory loss, cognitive and/or functional decline
Rule out organic causes:
- medication review
- lab tests for hypothyroidism and B12 deficiency
- Neuroimaging to rule out VD, hydrocephalus, tumors)
- Clinical assesment of depression to rule out psuedodementia
AD can only be confirmed via neurohistopathological examination, which can only be conducted post mortem
What are the diagnositic findings in Alzheimer’s dementia
Insidious onset (often first noticed by relatives) Objectively confirmed progressive loss of function in at least two cognitive domains (usually including memory impairment) Impaired activities of daily living No other plausible explanation (eg delirium)
How is Alzheimer’s managed
Repeated cognitive testing used to track disease progression
Functional testing
EEG - slower basic rhythm, evoked potentials with long latency
Neuroimaging:
CT/ MRI
- signs of generalised focal cerebral atrophy
- enlarged ventricles
-narrowing of gyri
- prominent cerbral sulci
-Disproportionate atrophy of the hippocampus and/or medial temporal lobe
Cerbrospinal fluid:
- ↑ Phospho-tau protein
- ↓ β-amyloid proteins Aβ1–42
How is alzheimer’s disease treated
Pharmacological treatment:
Mild to moderate:
- acetylcholinesterase inhibitors:
- Donepezil
- Galantamine
- Rivastigmine
Moderate to severe:
- in addition to acetylcholinesterase inhibitors, give NMDA-receptor antagonist:
- Memantine
Associated aggression and psychosis:
- low dose antipsychotics:
- atypical eg risperidone
- SSRIs eg citalopram in those with depression
Non-pharmacological Treatment:
Lifestyle modification:
- regular sleep schedule
- familiar environment
- remove ambient noise
Cognitive rehabilitiation:
- memory training (eg puzzles, interactive games) to support memory retention and strategies to compensate for cognitive and functional decline
Physical activity:
-improves physical strength which slows functional decline
Avoid drugs with strong anticholinergic effects (eg diphenhydramine)
What is the prognosis in Alzheimer’s dementia
Mean survival time is ~3 to 10 years after diagnosis
What are potential complications of Alzheimer’s dementia
Infections: aspiration pneumonia most common contriputing factor to AD-related mortality
Malnourishment/ dehydration
Intracerebral hameorrhage (↑ risk due to cerebral amyloid angiopathy)
What is vascular dementia
Gradual cognitive decline caused by small or large vessel disease
What is the epidemiology of vascualr dementia
Second most common type of dementia (15-20%)
Prevalenc eincreases with age
What is the aetiology of vascular dementia
Occurs as a result of a prolonged or severe cerebral ischaemia of any aetiology primarily:
- Large artery occlusion (usually cortical ischaemia)
- Lacunar stroke (small vessel occlusion resulting in subcortical ischaemia)
- Chronic subcortical ischaemia
What are the risk factors for vascular dementia
Advanced age History of stroke Underlying conditions associated with cardiovascular disease: - chronic hypertension - hyperglycaemia - hypercholesterolemia - hypertriglyceridemia - obesity
How does vascular dementia present
Symptoms depend on location of ischaemic events and so vary widely between pts
Small vessel:
- progress gradually or stepwise and slower than in multi-infarct dementia
- signs of subcortical pathology:
- Early symptoms
- – Reduced executive functioning
- – Loss of visuospatial abilities
- – Confusion
- – Apathy
- – Motor disorders (gait disturbance, urinary incontinence
- Later symptoms
- – Impaired memory
- – Further cognitive decline - loss of judgement, disorientation
- – Mood disorders - euphoria, depression
- – Behavioural changes - aggression
- Advanced stages
- – Further motor deteriation - dysphasia, dysarthria
Large vessel:
- usually sudden onset
- multi-infarct dementia
- typically stepwise deterioration
- signs of cortical pathology
- cognitive impairment in combination with asymmetric or focal deficits (eg unilateral visual field defects, hemiparesis, present Babinski reflex
- symptoms depend on affected cerebral region
How is vascular dementia diagnosed
Clinical diagnosis based on medical history, clinical features, MMSE testing and supported by imaging findings
Brain MRI: multiple cortical infarcts, subcortical infarcts (lacunes) and white matter lesions (periventricular and in the semioval centre)
Brain CT: microangiopathic lesions located in white matter, multiple lacunar lesion in the subcortical brain regions
PET-CT (functional imaging): may br helpful in distinguishing between AD and VD:
- VD- hypoperfusion and hypometabolism more pronounced in the frontal lobe
- AD- hypoperfusion and hypometabolism more pronounced in the patietal and temporal lobes
Ultrasound:
- Doppler exam of crital vessels (particularly the carotid arteries) for signs of cerebrovascular risk (atherosclerosis)
- Echocardiogram to evaluate the risk of cardioembolic events
Lab tests:
-GLucose
-TSH
To rule out other potential causes or comorbidities